Consistently, ONECUT2 methylation alone in our study was present in 8 of 10 bladder cancer patients and 10 of 10 recurrent patients (Additional file 1: Fig. S2), indicating the potential role of ONECUT2 methylation in bladder cancer diagnosis. This evidence concerns the gene ONECUT2 and urinary bladder cancer.